Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients
Quagliarello V, Viscoli C, Horwitz R. Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. The Lancet 1995, 345: 548-552. PMID: 7776774, DOI: 10.1016/s0140-6736(95)90465-4.Peer-Reviewed Original ResearchMeSH KeywordsAdultCase-Control StudiesCD4 Lymphocyte CountFemaleFluconazoleHIV InfectionsHumansMaleMeningitis, CryptococcalOdds RatioRegression AnalysisRiskConceptsHIV outpatient clinicCryptococcal meningitisFirst episodeCD4 countLumbar punctureUrban HIV outpatient clinicMean CD4 countUniversity Teaching HospitalCase-control studyOral fluconazolePrevious AIDSAntiretroviral therapyCryptococcal antigenCD4 cellsPrimary preventionProtective efficacyControl subjectsInsurance statusOdds ratioOral candidosisTeaching hospitalNumber of visitsCerebrospinal fluidMeningitisHIV